The strict application by the European Court of Justice of the law on generic approvals in the case of Generics (UK) Ltd v The Licensing Authority (acting via the Medicines and Healthcare products Regulatory Agency)1 is a victory for the innovative pharmaceutical industry
...
Please login to read the full article.
